Drug Profile
Research programme: liposomal curcumin - Plantacor/University of Texas M.D. Anderson Cancer Center
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator University of Texas M. D. Anderson Cancer Center
- Class Aromatic hydrocarbons; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in USA (Liposomal)
- 27 Jul 2004 Preclinical trials in Cancer in USA (unspecified route)